Introduction
The family of ®broblast growth factor (FGF) represents a large group of polypeptides that play important roles in embryonic development, tissue growth, wound healing, and angiogenesis (Burgess et al., 1989) . The prototypes of FGF, namely FGF-1 and FGF-2, are mitogenic and chemotactic for many mesenchymederived cells (Gospodarowicz, 1974; Maciag et al., 1982) . During the early response to FGF-1 or FGF-2, several intracellular proteins are phosphorylated at tyrosine residues (Huang et al., 1986) . These phosphotyrosyl proteins include phospholipase C g (PLC-g), Snt (or Frs2), Shc, Gab-1, and MAP kinases (Bogoyevitch et al., 1994; Burgess et al., 1990; Kouhara et al., 1997; Ong et al., 1997; Wang et al., 1994 Wang et al., , 1996 . Whereas PLC-g is important for FGF-mediated phosphatidylinositol turnover, it is not necessary for FGF-induced mitogenesis (Mohammadi et al., 1992; Peters et al., 1992) . Snt encodes a protein that has an electrophoretic motility around 90 kDa (Kouhara et al., 1997) and binds to FGF receptor 1 (FGFR-1) through its phosphotyrosine binding domain in a phosphotyrosine independent manner (Xu et al., 1998) . Snt functions as a lipidanchored docking protein and targets the signaling adaptor Grb-2, either directly or through Sph-2 protein tyrosine phosphatase, to the plasma membrane (Hadari et al., 1998; Kouhara et al., 1997) . Because Grb-2 binds to Sos, a Ras guanine nucleotide exchange factor Egan et al., 1993; Rozakis-Adcock et al., 1993) , Snt is likely to be a primary component involved in the activation of the complexes of Ras/Raf/mitogenactivated protein kinase (MAPK), the major signal pathway from the plasma membrane to the nucleus. Likewise, Gab-1 (an IRS-related protein) and Shc act also as signaling adaptors and are likely involved in the similar pathway to the activation of Ras (HolgadoMadruga et al., 1996; Rozakis-Adcock et al., 1992) . Although the exact roles of these molecules in the biological function of FGF are not fully elucidated, it is assumed that these factors may ultimately be important for the FGF's mitogenic activity.
It is less understood, however, how FGFs signal cell shape changes and migration. We have previously shown that FGF-1 requires a prolonged stimulation to reach a maximal mitogenic response (Zhan et al., 1993a) . Analysis of this late response (4 ± 12 h) has revealed a series of tyrosine phosphorylated proteins that are not apparent during the early response. One of these proteins was characterized as cortactin, a prominent substrate of Src protein tyrosine kinase (Zhan et al., 1993b) . Cortactin is also a potent crosslinker for ®lamentous actin (F-actin) (Huang et al., 1997) and co-localizes with F-actin in cell peripheral areas and punctate-like membrane structures (Wu et al., 1993) . We have recently described that the F-actin cross-linking activity of cortactin can be attenuated by Src-mediated tyrosine phosphorylation (Huang et al., 1997) . Furthermore, overexpression of a cortactin mutated at tyrosine phosphorylation sites impairs the migration of endothelial cells (Huang et al., 1998) . Therefore, these data indicate that cortactin acts as a modulator for the actin cytoskeleton.
The evidence for the role of Src in FGF signaling also begins emerging. In a previous investigation of FGF signaling, we described that the activated FGFR-1 is able to transiently associate with Src-like proteins in a manner dependent on tyrosine phosphorylation of FGFR-1 and the SH2 domain of Src (Zhan et al., 1994) . Overexpression of a normal Src can increase the response to FGF-1 mediated cellular scattering and motility (Rodier et al., 1995) . On the other hand, overexpression of a mutated form of Src inhibits the scattering response without aecting mitogenesis induced by FGF-1 or EGF. In addition, the early withdrawal of FGF-1 from culture medium can induce cell migration without promoting DNA synthesis, this property is apparently correlated with a transient increase in Src kinase activity (LaVallee et al., 1998) . While these studies suggest that a Src-related activity may be involved in a FGF signaling independent on mitogenesis, neither the speci®c Src family members nor particular Src substrates have been de®ned. Furthermore, direct genetic evidence for the role of Src in the growth factor induced cell migration is still missing. In this report, we examined whether Src is required for the FGF-1 mediated tyrosine phosphorylation of cortactin within the cells derived from Src knockout mice. We found that a cortactin mutated at the tyrosine residues that are targeted by Src is impaired to respond to FGF-1 stimulation. In addition, cells lacking the Src gene are able to undergo proliferation in the presence of FGF-1, though these cells show fewer changes in morphology and have slower motility compared to normal cells. Furthermore, FGF-1 is able to induce tyrosine phosphorylation of Snt but not cortactin in Src knockout cells. These ®ndings demonstrate that Src is the major kinase responsible for FGF-1-induced tyrosine phosphorylation of cortactin, and Src and cortactin are implicated in a signal pathway for cell migration and shape change, which is apparently distinct from that involved in the mitogenic response.
Results
Src is essential for the tyrosine phosphorylation of cortactin induced by FGF-1
In the attempt to verify that Src is required for the tyrosine phosphorylation of cortactin induced by FGF-1, we initially evaluated whether the tyrosine residues targeted by Src are necessary for FGF-1 mediated phosphorylation. In a previous study, we determined that the primary tyrosine residues targeted by Src reside at Tyr-421, Tyr-466 and Tyr-482 (Huang et al., 1998) . Thus, we analysed NIH3T3 cells expressing myc-Cort F421F466F482 , a cortactin mutant in which the three tyrosine residues are replaced with phenylalanines and the NH2-terminus is fused to the myc epitope (Huang et al., 1998) . As a control, a wildtype murine cortactin fused to the same myc epitope (myc-cortactin) was analysed in parallel. As shown in Figure 1 , the level of tyrosine phosphorylated myccortactin signi®cantly increased within 12 h after FGF-1 stimulation. In contrast, the mutant Cort F421F466F482 failed to increase in its tyrosine phosphorylation in response to FGF-1. This result indicates that the tyrosine phosphorylation of cortactin induced by FGF-1 occurs at the same residues that are targeted by Src.
To further con®rm the role of Src in the tyrosine phosphorylation of cortactin, we examined embryonic ®broblasts derived from the Src-knockout mice (Src
) and ®broblasts derived from a normal mouse embryo (Src
). The cells were maintained at near con¯uence in a serum-free de®ned medium supplemented with insulin (DMI) for 48 h and subsequently stimulated with FGF-1 for various times. The total cell lysates were prepared and analysed by immunophosphoty-rosine blot analysis. It appeared that Snt, which is a major FGF responsive protein and migrates at 90 kDa, was induced similarly in both types of cells ( Figure 2a ). (Figure 2a) . The p80 band apparently co-migrated with cortactin (data not shown), which was further con®rmed by immunoprecipitation with a cortactin antibody followed by immunophosphotyrosine blot analysis. As shown in Figure 2b , cortactin was hyperphosphorylated signi®cantly in Src +/+ cells after 12 h of FGF-1 stimulation. In contrast, it was weakly phosphorylated within Src 7/7 cells, although there was a slight increase in tyrosine phosphorylation of cortactin at 24 h of stimulation. This slight increase observed at 24 h was apparently due to a dierential sample loading as indicated by analysing the same blot using a cortactin antibody (Figure 2b , the lower panel). Interestingly, we also observed several other phosphotyrosyl bands including one of 70 kDa and two bands between 130 ± 200 kDa, which were actually enhanced in the FGF-1 stimulated Src 7/7 cells ( Figure 2a) . However, the identities of these bands are currently unknown. Taken together, these data demonstrated that Src is likely the primary kinase for FGF-induced phosphorylation of cortactin, and cortactin is apparently one of the major phosphotyrosyl proteins induced by FGF-1 in a Src-dependent manner.
Src is required for FGF-1-mediated cell shape change and migration
To elucidate the role of Src in the function of FGF-1, we also examined the morphological response of Src 7/7
and Src +/+ to FGF-1. Under serum-starved culture conditions, both types of cells exhibited a typical quiescent morphology characterized by a¯at monolayer (Figure 3) . When the cells were exposed to FGF- 1 for 12 h, Src +/+ cells underwent a signi®cant shape change typi®ed by a greatly elongated cytoplasm (Figure 3) . However, this change was not observed when Src 7/7 cells were analysed, although many of these cells round up after 12 h of FGF-1 stimulation. A close examination by confocal laser scanning microscopy also revealed a dierential cortactin staining between these two types of cells. While cortactin was found within the areas around the periphery, the peri-nucleus, and punctate-like structures within the cytoplasm of both quiescent cells (Figure 4a,e) , cortactin and F-actin co-stained abundantly within polarized lamellipodia, as de®ned by large intervening regions of the Src +/+ cells at 12 h stimulation (Figure 4g,h) . Concomitant with the association of more cortactin proteins with these polarized leading structures, less cortactin staining was detected in the peri-nucleus of FGF-1 treated Src +/+ cells. In contrast, the Src 7/7 cells treated with FGF-1 did not show signi®cantly polarized lamellipodia associated with cortactin and F-actin (Figure 4c,d) . Instead, cortactin was more enriched at the perinucleus within those cells (Figure 4c) .
The dierential response of these cells to FGF-1 with respect to the morphological changes was apparently correlated with their motility as analysed by a wound-healing assay. As shown in Figure 5 , both Src
7/7
and Src +/+ cells did not show apparent migration within 6 h into the wounded areas generated by a rubber policeman when FGF-1 was absent (Figure 5a,c) . In the presence of FGF-1, however, Src +/+ cells displayed extensive elongation of their cytoplasm. Concomitant with the elongated morphology, many Src +/+ cells were found in the wounded area (Figure 5d ). In contrast, few Src 7/7 cells showed migration, although many of them exhibited rounding-up morphology (Figure 5b ). Figure 5 The lack of Src impairs cell migration. Quiescent Src 7/7 (a and b) and Src +/+ cells (c and d) were stimulated with (b and d) or without FGF-1 (a and c). After 20 h of stimulation, the monolayers were wounded with a rubber policeman. The photographs were taken at 6 h after wounding Figure 6 The lack of Src does not aect cell proliferation. Src 7/7 and Src +/+ cells were seeded at 1610 4 cells per well in a 24-well plate. At 8 h after plating, the culture medium was changed to DMI supplemented with FGF-1 (10 ng/ml) and heparin (10 units/ml). In the control samples, cells were maintained in DMI. At the times indicated, cells were trypsinized and counted using a hemocytometer. Each time point represents a mean of three independent experiments. Labels: *, Src 7/7 in DMI only; &, Src 7/7 in DMI plus FGF-1;~, Src +/+ in DMI; and !, Src +/+ in DMI plus FGF-1
Src is not required for FGF-1 mediated cell proliferation
The rounding-up morphology exhibited by Src 7/7 cells in the presence of FGF-1 suggested that those cells were able to undergo mitosis. To further con®rm this notion, we have measured their proliferative response to FGF-1. Both Src 7/7 and Src +/+ cells were plated at approximately 5% con¯uence and maintained in DMI supplemented with FGF-1. As shown in Figure 6 , both types of cells grew in a FGF-1-dependent manner. Interestingly, Src 7/7 cells appeared to grow even faster than Src +/+ cells. The maximal number of Src 7/7 cells in the presence of FGF-1 was nearly four times higher than that of Src +/+ cells ( Figure 6 ). Thus, the lack of Src apparently does not inhibit but actually enhances the response to FGF-1 for proliferation.
Discussion
In this study, we provided evidence that Src is required for FGF-1-mediated shape change and cell migration. Our conclusion further supports the notion that Src plays a vital role in the signaling pathways for cell migration and shape change triggered by growth factors. However, our data also demonstrate that Src is not required for the FGF-1 mediated cell proliferation. In fact, the cells lacking Src grow much faster than normal cells (Figure 6 ). Consistent with the mitogenic response to FGF-1, the lack of Src does not impair the tyrosine phosphorylation of Snt (or Frs2). Snt has been shown to be a direct substrate for FGF receptors (Xu et al., 1998) . Because Snt shares homologous sequence with insulin receptor substrate 1, and binds to Grb-2 proteins, it is likely a major signaling molecule linking to the Ras/MAPK pathway and is essential for FGF's mitogenic activity. Thus, it appears that Src and cortactin are involved in a discrete signal pathway that primarily regulates the cytoskeletal changes. In support of this notion, transient FGF stimulation does not induce a maximum DNA synthesis but is able to induce the activation of Src and tyrosine phosphorylation of cortactin (LaVallee et al., 1998) . Furthermore, it is known that oncogenic Src (v-Src) transforms cells in a manner independent of MAPK, a key component for its mitogenic activity (Oldham et al., 1998) .
In light of the presence of many members in the Src family and other non-receptor tyrosine kinases (Thomas et al., 1997) , FGF-1 could utilize kinases other than Src to phosphorylate these molecules, as indicated by a recent report that FER, a non Srcrelated intracellular tyrosine kinases, is involved in a PDGF-mediated cortactin phosphorylation (Kim et al., 1998) . However, we found that the tyrosine phosphorylation of cortactin induced by FGF-1 is signi®cantly impaired in the cells de®cient in Src alone. Furthermore, the tyrosine residues targeted by Src are the same as those mediated by FGF-1 (Figure 1) . These results reinforce the notion that cortactin is a preferred substate for Src compared to other Src-related kinases (Thomas et al., 1995) . It is also noteworthy that cortactin is the major tyrosine phosphorylated protein that is impaired in FGF-1-induced Src 7/7 cells ( Figure  6a ).
Cortactin is a cell periphery-associated protein that binds to and cross-links ®lamentous actin (Huang et al., 1997; Zhan et al., 1993b) . In quiescent Src 7/7 or Src +/+ cells, cortactin localizes evenly around the cell margins. This is consistent with our previous report that a mutant lacking tyrosine phosphorylation sites is still able to associate with cell peripheral structures in endothelial cells (Huang et al., 1998) . However, in FGF-stimulated Src +/+ cells, the majority of cortactin was accumulated in the leading edges of the cells. This accumulation was apparently impaired within Src 7/7 cells, where cortactin is more concentrated around the nucleus. Thus, it appears that Src is required for the dynamic movement of cortactin within the cytoplasm. Interestingly, the rearranged cortactin co-localizes with F-actin either in newly formed lamellipodia in normal cells (Figure 4h ) or around the nucleus (Figure 4d ) in Src 7/7 cells, indicating that the movement of cortactin within cells is coupled with F-actin. A recent report has described that Rac is involved in the translocation of cortactin in PDGF-stimulated cells (Weed et al., 1998) . While Src can reportedly activate Ras-like GTPase (Chang et al., 1995; Schieer et al., 1996) , the lack of Src is unlikely to aect the activation of Rac in FGF treated cells because Src is not required for the activation of Snt, a primary signaling molecule that links to Ras, which in turn can activate Rac (Hall, 1998) . Alternatively, the dynamic movement of cortactin requires its tyrosine phosphorylation, which apparently attenuates its F-actin cross-linking activity (Huang et al., 1997) . It has been suggested that the movement of cellular particles is due to a retrograde actin¯ow, a movement of newly formed actin ®laments from the front of lamellipodia to the opposite direction of cell forward (Cramer, 1997) . One model for the driving actin retrograde¯ow is that disassociation of cross-linked actin network at the back of the lamellipodium will generate a tension gradient which can drive retrograde¯ow of actin (Mogilner et al., 1996) . Thus, it will be of interest to de®ne whether cortactin is involved in a driving force for actin retrograde¯ow. Further experiments using mutants for each of these pathways should dissect the mechanism for the cortactin translocation induced by FGF-1.
Materials and methods

Reagents
All chemicals unless otherwise indicated were from SigmaAldrich Inc. (St. Louis, MO, USA). Cortactin antibodies C001 and 2719 were prepared from rabbit as previously described (Zhan et al., 1994 (Zhan et al., , 1993b . Monoclonal antibody against the myc epitope 9E-10 was a gift from Tom Maciag (Maine Medical Center, Portland, ME, USA).
Cell culture
Embryonic ®broblasts derived from a Src knockout mouse (Src 7/7 , clone 1) and embryonic ®broblasts from a normal mouse (Src +/+ , clone 8) were obtained as gifts from Soriano Phillipo (Washington University, Seattle, WA, USA). Cells are cultured in Dulbecco's modi®ed Eagle's medium (DMEM) (Fisher Scienti®c, Pittsburgh, PA, USA) supplemented with 10% fetal calf serum and antibiotics. Quiescent monolayer cells were achieved by growing nearly to con¯uence in a serum free de®ned medium supplemented with 10 mg/ml insulin (DMI) for 48 h (Zhan et al., 1986) . The stimulation of FGF-1 was initiated by adding recombinant human FGF-1 (10 ng/ml) and heparin (10 units/ml) to the culture.
Cell migration
Quiescent Src
7/7 and Src +/+ cells were stimulated with FGF-1 as described above. After 20 h of stimulation, monolayers of the cells were wounded with a rubber policeman (2 mm wide). The cultures were photographed after 6 h of wounding.
Cell growth assay
Cells were seeded at 1610 4 cells per well in a 24-well plate containing DMEM supplemented with 10% calf serum. At 8 h after seeding, the medium was changed to DMI supplemented with FGF-1 (10 ng/ml) and heparin (10 units/ ml). In the control samples, DMI without FGF-1 was applied. The treated cells were harvested by trypsinization at the times indicated and counted under a phase-contrast microscope using a hemocytometer. For each time point, three wells of culture were analysed.
Analysis of tyrosine phosphorylation of cortactin
Quiescent cells were stimulated with FGF-1 as described above. At the times indicated, cells were harvested and lysed in RIPA buer (10 mM Tris-HCl, pH 7.5, 1.0 mM EDTA, 150 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 0.5% sodium deoxycholate, 1.0 mM sodium orthovanadate, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1.0 mM phenylmethylsulfonyl¯uoride), and clari®ed by centrifugation in a microcentrifuge for 10 min. The supernatants were immunoprecipitated with anti-cortactin antibody 2719 (Zhan et al., 1993b) . The immunoprecipitates were then resolved in a SDS-polyacrylamide gel electrophoresis (PAGE) (7.5%, w/v), transferred to a nitrocellulose membrane and further probed with anti-phosphotyrosine antibody (4G10, Upstate Biotechnology Inc. Lake Placid, NY, USA). The blot membrane was stripped and re-probed with the monoclonal cortactin antibody 4F11 (Upstate Biotechnology Inc. Lake Placid, NY, USA) (Wu et al., 1993) .
Analysis of cortactin mutants in NIH3T3 cells
The plasmid pMyc-cortactin (encoding a murine cortactin tagged by the myc epitope at its NH 2 -terminus) and p-MycCort F421F466F482 (encoding a murine cortactin where tyrosine residues 421, 466 and 482 were changed to phenylalanine) were previously described (Huang et al., 1998) . The two plasmids were transfected into NIH3T3 cells with the Transfection MBS Mammalian Transfection Kit according to the manufacturer's recommended procedure (Stratagene, La Jolla, CA, USA). Stable transfectants were subsequently selected in DMEM containing 10% calf serum and 0.8 mg/ml G418 (Life Technologies, Gaithersburg, MD, USA). Quiescent transfected cells were stimulated with FGF-1 for 12 h and the cell lysates were immunoprecipitated with 9E-10 antibody against the myc-epitope. The precipitates were then subjected to immunoblot with a polyclonal phosphotyrosine antibody (Zhan et al., 1993a) . The blot was stripped and then re-probed with cortactin antibody C001.
Immuno¯uorescent analysis
Src
7/7 and Src +/+ cells were grown on ®bronectin-coated glass cover slips and maintained in DMI for 48 h. Cells were then stimulated with FGF-1 for overnight, double stained with cortactin antibody C001 and¯uorescein-isothiocyanatephalloidin, and examined by confocal laser microscopy as previously described (Huang et al., 1998) .
Abbreviations F-actin, ®lamentous actin; FGF, ®broblast growth factor; DMI, de®ned serum-free medium supplemented with insulin; PAGE, polyacrylamide gel electrophoresis; FITC, uorescein-isothiocyanate; PLC, phospholipase C.
